Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2125173 | 0.88 | CA2 (0.41) | CA2CA1CA7CA13MMP1 | |
| SCHEMBL2124886 | 0.84 | CA2 (0.50) | CA2CA1CA7CA13MMP1 | |
| SCHEMBL7140442 | 0.82 | CA2 (0.37) | CA2CA1CA7CA13 | |
| SCHEMBL24685503 | 0.79 | CA1 (0.35) | CA2CA1CA7CA13 | |
| SCHEMBL2607862 | 0.79 | CA1 (0.35) | CA2CA1CA7CA13 | |
| SCHEMBL13822435 | 0.79 | CA1 (0.35) | CA2CA1CA7CA13 | |
| SCHEMBL9947155 | 0.79 | CA1 (0.35) | CA2CA1CA7CA13 | |
| SCHEMBL776311 | 0.77 | CA2 (0.43) | CA2CA1CA7CA13MMP1 | |
| Lithium SCHEMBL30354992 | 0.77 | CA1 (0.33) | CA2CA1CA7CA13 | |
| SCHEMBL774916 | 0.74 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 436 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3072178-B1 | USE OF LITHIUM BIS(FLUOROSULFONYL) IMIDE (LIFSI) IN NON-AQUEOUS ELECTROLYTE SOLUTIONS FOR USE WITH 4.2V AND HIGHER CATHODE MATERIALS FOR LITHIUM ION BATTERIES | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2019-04-10 | — | — | EP | claimed |
| US-9698447-B2 | Use of lithium bis(fluorosulfonyl) imide (LiFSI) in non-aqueous electrolyte solutions for use with 4.2v and higher cathode materials for lithium ion batteries | BASF CORPORATION (US) | 2017-07-04 | — | — | US | claimed |
| EP-3072178-A1 | USE OF LITHIUM BIS(FLUOROSULFONYL) IMIDE (LIFSI) IN NON-AQUEOUS ELECTROLYTE SOLUTIONS FOR USE WITH 4.2V AND HIGHER CATHODE MATERIALS FOR LITHIUM ION BATTERIES | BASF Corporation (US) | 2016-09-28 | — | — | EP | claimed |
| US-20150140446-A1 | Use Of Lithium Bis(Fluorosulfonyl) Imide (LIFSI) In Non-Aqueous Electrolyte Solutions For Use With 4.2v And Higher Cathode Materials For Lithium Ion Batteries | BASF CORPORATION (US) | 2015-05-21 | — | — | US | claimed |
| US-8764853-B2 | Non-aqueous electrolytic solutions and electrochemical cells comprising the same | BASF CORPORATION (US) | 2014-07-01 | — | — | US | claimed |
| US-8715865-B2 | Non-aqueous electrolytic solutions and electrochemical cells comprising the same | BASF CORPORATION (US) | 2014-05-06 | — | — | US | claimed |
| US-20130167363-A1 | Non-aqueous Electrolytic Solutions And Electrochemical Cells Comprising The Same | Novolyte Technologies, Inc. (US) | 2013-07-04 | — | — | US | claimed |
| JP-2010533359-A | — | — | 2010-10-21 | — | — | JP | claimed |
| US-20100137134-A1 | Pesticidal Mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2010-06-03 | — | — | US | claimed |
| EP-2183809-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTIONS AND ELECTROCHEMICAL CELLS COMPRISING THE SAME | Novolyte Technologies Inc. (US) | 2010-05-12 | — | — | EP | claimed |
| US-20090017386-A1 | Non-Aqueous Electrolytic Solutions And Electrochemical Cells Comprising The Same | FERRO CORPORATION (US) | 2009-01-15 | — | — | US | claimed |
| WO-2009009251-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTIONS AND ELECTROCHEMICAL CELLS COMPRISING THE SAME | FERRO CORPORATION (US) | 2009-01-15 | — | — | WO | claimed |
| EP-1915056-A2 | PESTICIDAL MIXTURES | BASF SE (DE) | 2008-04-30 | — | — | EP | claimed |
| WO-2007017433-A2 | PESTICIDAL MIXTURES | BASF SE (DE) | 2007-02-15 | — | — | WO | claimed |
| EP-1501792-B1 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M INNOVATIVE PROPERTIES CO (US) | 2007-02-14 | — | — | EP | claimed |
| EP-1501792-A2 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M Innovative Properties Company (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003095422-A2 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-11-20 | — | — | WO | claimed |
| US-6580006-B1 | Reacting tetrafluoroethylene and sulfuryl fluoride in presence of metal fluoride and crown ether | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-17 | — | — | US | claimed |
| CN-115458808-B | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-5480568-A | FOR LUBRICATING METAL CONTAINING SURFACES | THE DOW CHEMICAL COMPANY (US) | 1996-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137134-A1 | Pesticidal Mixtures | TYRO3, PAOX, GABBR1 | CA2 121/4885CA1 1470/4885CA7 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.